Efficacy and Safety of Activated Recombinant Human Factor VII in Treatment of Bleeding in Patients Following Hematopoietic Stem Cell Transplantation

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2002
This trial is conducted in the United States of America (USA). The aim of this trial is to evaluate the efficacy of activated recombinant human factor VII in treatment of bleeding in patients having undergone a hematopoietic stem cell transplantation.
Epistemonikos ID: 869345fa3c6150933adf30099f38cf04b014b43e
First added on: May 10, 2024